Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 878-886

  Milano, Michael T ^a   Katz, Alan W ^a   Zhang, Hong ^a   Okunieff, Paul ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Breast cancer; Metastases; Oligometastases; Stereotactic body radiotherapy; Survival

Indexed keywords

BREAST CANCER; METASTASES; OLIGOMETASTASES; STEREOTACTIC BODY RADIOTHERAPY; SURVIVAL;

BONE; DISEASE CONTROL; DISEASES; RADIOTHERAPY; REGRESSION ANALYSIS;

PATHOLOGY;

ABDOMINAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISTANT METASTASIS; FOLLOW UP; HUMAN; LIVER METASTASIS; LONG TERM SURVIVAL; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PELVIS METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RADIOSURGERY; SARCOMA;

EID: 84861581912     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.036     Document Type: Article

References (58)

1. R.R. Weichselbaum, and S. Hellman Oligometastases revisited Nat Rev Clin Oncol 8 2011 378 382
2. R.D. Timmerman, C.S. Bizekis, and H.I. Pass Local surgical, ablative, and radiation treatment of metastases CA Cancer J Clin 59 2009 145 170
3. S.A. Rosenberg Surgical treatment of metastatic cancer 1987 Lippincott Williams & Wilkins Philadelphia
4. P. Rubin, and J. Green Solitary metastases 1968 Charles C. Thomas Springfield, IL
5. B. Kuvshinoff, and Y. Fong Surgical therapy of liver metastases Semin Oncol 34 2007 177 185
6. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases Ann Surg 230 1999 309 321
7. R.E. Brown, M.R. Bower, and R.C. Martin Hepatic resection for colorectal liver metastases Surg Clin North Am 90 2010 839 852
8. N. Mahmoud, and K. Bullard Dunn Metastasectomy for stage IV colorectal cancer Dis Colon Rectum 53 2010 1080 1092
9. A. Al-Asfoor, Z. Fedorowicz, and M. Lodge Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases Cochrane Database Syst Rev 2008 CD006039
10. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases J Thorac Cardiovasc Surg 113 1997 37 49
11. D.I. Sternberg, and J.R. Sonett Surgical therapy of lung metastases Semin Oncol 34 2007 186 196
12. K.G. Billingsley, M.E. Burt, and E. Jara Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of diseases and postmetastasis survival Ann Surg 229 1999 602 610 602
13. S.H. Blackmon, N. Shah, and J.A. Roth Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival Ann Thorac Surg 88 2009 877 884 875
14. S. Hellman, and R.R. Weichselbaum Oligometastases J Clin Oncol 13 1995 8 10
15. A.C. Hartford, M.G. Palisca, and T.J. Eichler American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for intensity-modulated radiation therapy (IMRT) Int J Radiat Oncol Biol Phys 73 2009 9 14
16. L. Potters, L.E. Gaspar, and B. Kavanagh American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT) Int J Radiat Oncol Biol Phys 76 2010 319 325
17. L. Potters, B. Kavanagh, and J.M. Galvin American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 76 2010 326 332
18. S.H. Benedict, K.M. Yenice, and D. Followill Stereotactic body radiation therapy: The report of AAPM Task Group 101 Med Phys 37 2010 4078 4101
19. S.S. Lo, A.J. Fakiris, and E.L. Chang Stereotactic body radiation therapy: A novel treatment modality Nat Rev Clin Oncol 7 2010 44 54
20. A.W. Katz, M. Carey-Sampson, and A.G. Muhs Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases Int J Radiat Oncol Biol Phys 67 2006 793 798
21. M.T. Milano, A.W. Katz, and A.G. Muhs A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions Cancer 112 2008 650 658
22. M.T. Milano, A.W. Katz, and M.C. Schell Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 72 2008 1516 1522
23. M.T. Milano, H. Zhang, and S.K. Metcalfe Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy Breast Cancer Res Treat 115 2009 601 608
24. P. Okunieff, A.L. Petersen, and A. Philip Stereotactic body radiation therapy (SBRT) for lung metastases Acta Oncol 45 2006 808 817
25. S.S. Lo, A.J. Fakiris, and B.S. Teh Stereotactic body radiation therapy for oligometastases Expert Rev Anticancer Ther 9 2009 621 635
26. D.M. Macdermed, R.R. Weichselbaum, and J.K. Salama A rationale for the targeted treatment of oligometastases with radiotherapy J Surg Oncol 98 2008 202 206
27. B.D. Kavanagh, R.C. McGarry, and R.D. Timmerman Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases Semin Radiat Oncol 16 2006 77 84
28. M. Carey Sampson, A. Katz, and L.S. Constine Stereotactic body radiation therapy for extracranial oligometastases: Does the sword have a double edge? Semin Radiat Oncol 16 2006 67 76
29. S. Siva, M. MacManus, and D. Ball Stereotactic radiotherapy for pulmonary oligometastases: A systematic review J Thorac Oncol 5 2010 1091 1099
30. K.E. Rusthoven, B.D. Kavanagh, and S.H. Burri Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases J Clin Oncol 27 2009 1579 1584
31. K.E. Rusthoven, B.D. Kavanagh, and H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
32. M.T. Lee, J.J. Kim, and R. Dinniwell Phase I study of individualized stereotactic body radiotherapy of liver metastases J Clin Oncol 27 2009 1585 1591
33. O. Dawood, A. Mahadevan, and K.A. Goodman Stereotactic body radiation therapy for liver metastases Eur J Cancer 45 2009 2947 2959
34. J.K. Salama, S.J. Chmura, and N. Mehta An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease Clin Cancer Res 14 2008 5255 5259
35. J. Kao, S. Packer, and H.L. Vu Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: Acute toxicity and preliminary response Cancer 115 2009 3571 3580
36. M. Hoyer, H. Roed, and A. Traberg Hansen Phase II study on stereotactic body radiotherapy of colorectal metastases Acta Oncol 45 2006 823 830
37. P.J. Wersall, H. Blomgren, and I. Lax Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma Radiother Oncol 77 2005 88 95
38. A.J. Khan, P.S. Mehta, and T.W. Zusag Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC) Radiother Oncol 81 2006 163 167
39. M.T. Milano, A. Philip, and P. Okunieff Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses Int J Radiat Oncol Biol Phys 73 2009 832 837
40. W.G. O'Dell, M.C. Schell, and D. Reynolds Dose broadening due to target position variability during fractionated breath-held radiation therapy Med Phys 29 2002 1430 1437
41. M.T. Milano, L.S. Constine, and P. Okunieff Normal tissue toxicity after small field hypofractionated stereotactic body radiation Radiat Oncol 3 2008 36
42. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
43. N. Mehta, A.M. Mauer, and S. Hellman Analysis of further disease progression in metastatic non-small cell lung cancer: Implications for locoregional treatment Int J Oncol 25 2004 1677 1683
44. K.E. Rusthoven, S.F. Hammerman, and B.D. Kavanagh Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis Acta Oncol 48 2009 578 583
45. P. Cheruvu, S.K. Metcalfe, and J.D. Metcalfe Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer Radiat Oncol 6 2011 80
46. R. McCammon, T.E. Schefter, and L.E. Gaspar Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 2009 112 118
47. J.K. Kang, M.S. Kim, and J.H. Kim Oligometastases confined one organ from colorectal cancer treated by SBRT Clin Exp Metastasis 27 2010 273 278
48. M.S. Kim, S.Y. Yoo, and C.K. Cho Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer Oncology 76 2009 212 219
49. Y. Oh, S. Taylor, and B.N. Bekele Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases Cancer 115 2009 2930 2938
50. K. Basaki, Y. Abe, and M. Aoki Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume Int J Radiat Oncol Biol Phys 64 2006 449 454
51. J.D. Bradley, N. Ieumwananonthachai, and J.A. Purdy Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 52 2002 49 57
52. T.H. La, E.J. Filion, and B.B. Turnbull Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2009 1335 1341
53. P. Lee, D.K. Weerasuriya, and P.W. Lavori Metabolic tumor burden predicts for disease progression and death in lung cancer Int J Radiat Oncol Biol Phys 69 2007 328 333
54. B.M. Alexander, M. Othus, and H.B. Caglar Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy Int J Radiat Oncol Biol Phys 79 2011 1381 1387
55. Metcalfe SK, Ishikawa H, Milano MT, et al. GM-CSF and IFNgamma up-regulation with stereotactic body radiation therapy for oligometastatic breast cancer correlates with improved overall survival. Proceedings of the American Radium Society 2010; S046. Available at: http://www. americanradiumsociety.org/meeting-archives/2010/Tuesday/S046/
56. S. Formenti, K. Friedman, and K. Chao Abscopal response in irradiated patients: Results of a proof of priniciple trial Int J Radiat Oncol Biol Phys 72 2008 S6 S7
57. S.C. Formenti, and S. Demaria Systemic effects of local radiotherapy Lancet Oncol 10 2009 718 726
58. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159